Literature DB >> 9441921

Health risk assessment practices in the U.S. Food and Drug Administration.

D W Gaylor1, J A Axelrad, R P Brown, J A Cavagnaro, W H Cyr, K L Hulebak, R J Lorentzen, M A Miller, L T Mulligan, B A Schwetz.   

Abstract

The U.S. Food and Drug Administration (FDA) regulates a wide variety of consumer products. Safety issues involve chemical and microbial contaminants in food, biologies, and medical devices; side effects from prescription and nonprescription drugs; residues of animal drugs in food; and radiation from electronic devices. Because of this wide diversity, the legal standards, rules, and policies governing the regulation of these products differ considerably. Hence, risk assessment and risk management practices within the FDA are of necessity quite diverse. This paper presents a summary of risk assessment practices at each of the product centers of the FDA (Center for Food Safety and Applied Nutrition, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Veterinary Medicine) and of the development of risk assessment procedures at the National Center for Toxicological Research.

Mesh:

Year:  1997        PMID: 9441921     DOI: 10.1006/rtph.1997.1156

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  2 in total

1.  Obsolete pesticide storage sites and their POP release into the environment--an Armenian case study.

Authors:  A Dvorská; M Sír; Z Honzajková; J Komprda; P Cupr; J Petrlík; E Anakhasyan; L Simonyan; M Kubal
Journal:  Environ Sci Pollut Res Int       Date:  2012-07-06       Impact factor: 4.223

Review 2.  Approaches to detecting immunotoxic effects of environmental contaminants in humans.

Authors:  H Tryphonas
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.